The present disclosure is related to signal processing systems and methods, and more particularly, to systems and methods for selecting a consistent portion of a signal for parameter identification.
In an embodiment, a signal may be obtained, and a portion of the obtained signal may be analyzed for consistency. Signal extrema (e.g., local maxima and/or minima in the signal amplitude versus time) may be identified, and characteristics of the signal extrema may be analyzed to determine signal consistency. In an embodiment, signal peaks (local maxima in the signal amplitude versus time) may be identified and processed based on a consistency metric. The processed signal peaks may then be compared to the consistency metric, and the most consistent portion of the obtained signal (or a sufficiently consistent part of the obtained signal) may be identified in this way. In an embodiment, a consistent portion of a signal is found and used to determine an underlying parameter from the obtained signal. For example, a consistent portion of the signal may be used to determine a respiration rate of a patient.
For the purposes of illustration, and not by way of limitation, in an embodiment disclosed herein the obtained signal is a photoplethysmograph (PPG) signal drawn from any suitable source, such as a pulse oximeter. The obtained signal may be filtered, processed or otherwise transformed before the techniques described herein are applied to the signal. For example, the PPG signal may first be transformed by detecting and processing the up and down strokes of a preliminary PPG signal to produce the obtained PPG signal. Further, transformation of the preliminary PPG signal into the obtained PPG signal may include low-pass filtering, removal of noise-components, and/or interpolation methods to remove various undesirable artifacts that may be present in the preliminary PPG signal.
In an embodiment, a consistent portion of a (obtained) PPG signal may be determined by identifying the amplitude levels of one or more signal peaks. For example, a signal peak may be identified and lower and an upper thresholds may be set relative to the amplitude level of the signal peak. In an embodiment, a lower threshold may be set at an amplitude level smaller than the amplitude level of the PPG signal peak, and an upper threshold may be set at an amplitude level larger than the amplitude level of the PPG signal peak. An amplitude level of a second PPG signal peak may be identified, and a computer or process may then determine if the amplitude level of the second PPG signal peak is larger than the lower threshold amplitude level and smaller than the upper threshold amplitude level. If the amplitude level of the second PPG signal peak is larger than the lower threshold amplitude level and smaller than the upper threshold amplitude level, then the corresponding portion of the obtained PPG signal may be determined to be consistent.
In an embodiment, a consistent portion of a PPG signal may be found by analyzing interpeak distances (e.g., the time-distance between consecutive signal peaks). In an embodiment, an interpeak distance of an obtained PPG signal may be determined and compared to one or more additional interpeak distances. In an embodiment, the first interpeak distance may be compared to a threshold. If it is determined that the first interpeak distance exceeds the threshold, the first interpeak distance may be compared to past and future interpeak distance values. In an embodiment, a portion of the obtained PPG signal corresponding to an inconsistent interpeak distance is removed from the PPG signal. In an embodiment, if it is determined that the first interpeak distance does not exceed a threshold, the corresponding portion of the PPG signal may be determined to be consistent and used to determine one or more parameters inferable from the obtained PPG signal. For example, the respiration rate of a patient may be determined based on a portion of the PPG signal that is determined to be consistent.
The above and other features of the present disclosure, its nature and various advantages will be more apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings in which:
An oximeter is a medical device that may determine the oxygen saturation of the blood. One common type of oximeter is a pulse oximeter, which may indirectly measure the oxygen saturation of a patient's blood (as opposed to measuring oxygen saturation directly by analyzing a blood sample taken from the patient) and changes in blood volume in the skin. Ancillary to the blood oxygen saturation measurement, pulse oximeters may also be used to measure the pulse rate of the patient. Pulse oximeters typically measure and display various blood flow characteristics including, but not limited to, the oxygen saturation of hemoglobin in arterial blood.
An oximeter may include a light sensor that is placed at a site on a patient, typically a fingertip, toe, forehead or earlobe, or in the case of a neonate, across a foot. The oximeter may pass light using a light source through blood perfused tissue and photoelectrically sense the absorption of light in the tissue. For example, the oximeter may measure the intensity of light that is received at the light sensor as a function of time. A signal representing light intensity versus time or a mathematical manipulation of this signal (e.g., a scaled version thereof, a log taken thereof, a scaled version of a log taken thereof, etc.) may be referred to as the photoplethysmograph (PPG) signal. In addition, the term “PPG signal,” as used herein, may also refer to an absorption signal (i.e., representing the amount of light absorbed by the tissue) or any suitable mathematical manipulation thereof. The light intensity or the amount of light absorbed may then be used to calculate the amount of the blood constituent (e.g., oxyhemoglobin) being measured as well as the pulse rate and when each individual pulse occurs.
The light passed through the tissue is selected to be of one or more wavelengths that are absorbed by the blood in an amount representative of the amount of the blood constituent present in the blood. The amount of light passed through the tissue varies in accordance with the changing amount of blood constituent in the tissue and the related light absorption. Red and infrared wavelengths may be used because it has been observed that highly oxygenated blood will absorb relatively less red light and more infrared light than blood with a lower oxygen saturation. By comparing the intensities of two wavelengths at different points in the pulse cycle, it is possible to estimate the blood oxygen saturation of hemoglobin in arterial blood.
When the measured blood parameter is the oxygen saturation of hemoglobin, a convenient starting point assumes a saturation calculation based on Lambert-Beer's law. The following notation will be used herein:
I(λ,t)=Io(λ)exp(−(sβo(λ)+(1−s)βr(λ))l(t)) (1)
where:
λ=wavelength;
t=time;
I=intensity of light detected;
Io=intensity of light transmitted;
s=oxygen saturation;
βo, βr=empirically derived absorption coefficients; and
l(t)=a combination of concentration and path length from emitter to detector as a function of time.
The traditional approach measures light absorption at two wavelengths (e.g., red and infrared (IR)), and then calculates saturation by solving for the “ratio of ratios” as follows.
1. First, the natural logarithm of (1) is taken (“log” will be used to represent the natural logarithm) for IR and Red
log I=log Io−(sβo+(1−s)βr)l (2)
2. (2) is then differentiated with respect to time
3. Red (3) is divided by IR (3)
4. Solving for s
Note in discrete time
Using log A−log B=log A/B,
So, (4) can be rewritten as
where R represents the “ratio of ratios.” Solving (4) for s using (5) gives
From (5), R can be calculated using two points (e.g., PPG maximum and minimum), or a family of points. One method using a family of points uses a modified version of (5). Using the relationship
now (5) becomes
which defines a cluster of points whose slope of y versus x will give R where
x(t)=[I(t2,λIR)−I(t1,λIR)]I(t1,λR)
y(t)=[I(t2,λR)−I(t1,λR)]I(t1,λIR)
y(t)=Rx(t) (8)
According to another embodiment and as will be described, system 10 may include a plurality of sensors forming a sensor array in lieu of single sensor 12. Each of the sensors of the sensor array may be a complementary metal oxide semiconductor (CMOS) sensor. Alternatively, each sensor of the array may be charged coupled device (CCD) sensor. In another embodiment, the sensor array may be made up of a combination of CMOS and CCD sensors. The CCD sensor may comprise a photoactive region and a transmission region for receiving and transmitting data whereas the CMOS sensor may be made up of an integrated circuit having an array of pixel sensors. Each pixel may have a photodetector and an active amplifier.
According to an embodiment, emitter 16 and detector 18 may be on opposite sides of a digit such as a finger or toe, in which case the light that is emanating from the tissue has passed completely through the digit. In an embodiment, emitter 16 and detector 18 may be arranged so that light from emitter 16 penetrates the tissue and is reflected by the tissue into detector 18, such as a sensor designed to obtain pulse oximetry data from a patient's forehead.
In an embodiment, the sensor or sensor array may be connected to and draw its power from monitor 14 as shown. In another embodiment, the sensor may be wirelessly connected to monitor 14 and include its own battery or similar power supply (not shown). Monitor 14 may be configured to calculate physiological parameters based at least in part on data received from sensor 12 relating to light emission and detection. In an alternative embodiment, the calculations may be performed on the monitoring device itself and the result of the oximetry reading may be passed to monitor 14. Further, monitor 14 may include a display 20 configured to display the physiological parameters or other information about the system. In the embodiment shown, monitor 14 may also include a speaker 22 to provide an audible sound that may be used in various other embodiments, such as for example, sounding an audible alarm in the event that a patient's physiological parameters are not within a predefined normal range.
In an embodiment, sensor 12, or the sensor array, may be communicatively coupled to monitor 14 via a cable 24. However, in other embodiments, a wireless transmission device (not shown) or the like may be used instead of or in addition to cable 24.
In the illustrated embodiment, pulse oximetry system 10 may also include a multi-parameter patient monitor 26. The monitor may be cathode ray tube type, a flat panel display (as shown) such as a liquid crystal display (LCD) or a plasma display, or any other type of monitor now known or later developed. Multi-parameter patient monitor 26 may be configured to calculate physiological parameters and to provide a display 28 for information from monitor 14 and from other medical monitoring devices or systems (not shown). For example, multiparameter patient monitor 26 may be configured to display an estimate of a patient's blood oxygen saturation generated by pulse oximetry monitor 14 (referred to as an “SpO2” measurement), pulse rate information from monitor 14 and blood pressure from a blood pressure monitor (not shown) on display 28.
Monitor 14 may be communicatively coupled to multi-parameter patient monitor 26 via a cable 32 or 34 that is coupled to a sensor input port or a digital communications port, respectively and/or may communicate wirelessly (not shown). In addition, monitor 14 and/or multi-parameter patient monitor 26 may be coupled to a network to enable the sharing of information with servers or other workstations (not shown). Monitor 14 may be powered by a battery (not shown) or by a conventional power source such as a wall outlet.
It will be understood that, as used herein, the term “light” may refer to energy produced by radiative sources and may include one or more of ultrasound, radio, microwave, millimeter wave, infrared, visible, ultraviolet, gamma ray or X-ray electromagnetic radiation. As used herein, light may also include any wavelength within the radio, microwave, infrared, visible, ultraviolet, or X-ray spectra, and that any suitable wavelength of electromagnetic radiation may be appropriate for use with the present techniques. Detector 18 may be chosen to be specifically sensitive to the chosen targeted energy spectrum of the emitter 16.
In an embodiment, detector 18 may be configured to detect the intensity of light at the RED and IR wavelengths. Alternatively, each sensor in the array may be configured to detect an intensity of a single wavelength. In operation, light may enter detector 18 after passing through the patient's tissue 40. Detector 18 may convert the intensity of the received light into an electrical signal. The light intensity is directly related to the absorbance and/or reflectance of light in the tissue 40. That is, when more light at a certain wavelength is absorbed or reflected, less light of that wavelength is received from the tissue by the detector 18. After converting the received light to an electrical signal, detector 18 may send the signal to monitor 14, where physiological parameters may be calculated based on the absorption of the RED and IR wavelengths in the patient's tissue 40.
In an embodiment, encoder 42 may contain information about sensor 12, such as what type of sensor it is (e.g., whether the sensor is intended for placement on a forehead or digit) and the wavelengths of light emitted by emitter 16. This information may be used by monitor 14 to select appropriate algorithms, lookup tables and/or calibration coefficients stored in monitor 14 for calculating the patient's physiological parameters.
Encoder 42 may contain information specific to patient 40, such as, for example, the patient's age, weight, and diagnosis. This information may allow monitor 14 to determine, for example, patient-specific threshold ranges in which the patient's physiological parameter measurements should fall and to enable or disable additional physiological parameter algorithms. Encoder 42 may, for instance, be a coded resistor which stores values corresponding to the type of sensor 12 or the type of each sensor in the sensor array, the wavelengths of light emitted by emitter 16 on each sensor of the sensor array, and/or the patient's characteristics. In another embodiment, encoder 42 may include a memory on which one or more of the following information may be stored for communication to monitor 14: the type of the sensor 12; the wavelengths of light emitted by emitter 16; the particular wavelength each sensor in the sensor array is monitoring; a signal threshold for each sensor in the sensor array; any other suitable information; or any combination thereof.
In an embodiment, signals from detector 18 and encoder 42 may be transmitted to monitor 14. In the embodiment shown, monitor 14 may include a general-purpose microprocessor 48 connected to an internal bus 50. Microprocessor 48 may be adapted to execute software, which may include an operating system and one or more applications, as part of performing the functions described herein. Also connected to bus 50 may be a read-only memory (ROM) 52, a random access memory (RAM) 54, user inputs 56, display 20, and speaker 22.
RAM 54 and ROM 52 are illustrated by way of example, and not limitation. Any suitable computer-readable media may be used in the system for data storage. Computer-readable media are capable of storing information that can be interpreted by microprocessor 48. This information may be data or may take the form of computer-executable instructions, such as software applications, that cause the microprocessor to perform certain functions and/or computer-implemented methods. Depending on the embodiment, such computer-readable media may include computer storage media and communication media. Computer storage media may include volatile and non-volatile, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable instructions, data structures, program modules or other data. Computer storage media may include, but is not limited to, RAM, ROM, EPROM, EEPROM, flash memory or other solid state memory technology, CD-ROM, DVD, or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and which can be accessed by components of the system.
In the embodiment shown, a time processing unit (TPU) 58 may provide timing control signals to a light drive circuitry 60, which may control when emitter 16 is illuminated and multiplexed timing for the RED LED 44 and the IR LED 46. TPU 58 may also control the gating-in of signals from detector 18 through an amplifier 62 and a switching circuit 64. These signals are sampled at the proper time, depending upon which light source is illuminated. The received signal from detector 18 may be passed through an amplifier 66, a low pass filter 68, and an analog-to-digital converter 70. The digital data may then be stored in a queued serial module (QSM) 72 (or buffer) for later downloading to RAM 54 as QSM 72 fills up. In one embodiment, there may be multiple separate parallel paths having amplifier 66, filter 68, and A/D converter 70 for multiple light wavelengths or spectra received.
In an embodiment, microprocessor 48 may determine the patient's physiological parameters, such as SpO2 and pulse rate, using various algorithms and/or look-up tables based on the value of the received signals and/or data corresponding to the light received by detector 18. Signals corresponding to information about patient 40, and particularly about the intensity of light emanating from a patient's tissue over time, may be transmitted from encoder 42 to a decoder 74. These signals may include, for example, encoded information relating to patient characteristics. Decoder 74 may translate these signals to enable the microprocessor to determine the thresholds based on algorithms or look-up tables stored in ROM 52. User inputs 56 may be used to enter information about the patient, such as age, weight, height, diagnosis, medications, treatments, and so forth. In an embodiment, display 20 may exhibit a list of values which may generally apply to the patient, such as, for example, age ranges or medication families, which the user may select using user inputs 56.
The optical signal through the tissue can be degraded by noise, among other sources. One source of noise is ambient light that reaches the light detector. Another source of noise is electromagnetic coupling from other electronic instruments. Movement of the patient also introduces noise and affects the signal. For example, the contact between the detector and the skin, or the emitter and the skin, can be temporarily disrupted when movement causes either to move away from the skin. In addition, because blood is a fluid, it responds differently than the surrounding tissue to inertial effects, thus resulting in momentary changes in volume at the point to which the oximeter probe is attached.
Noise (e.g., from patient movement) can degrade a pulse oximetry signal relied upon by a physician, without the physician's awareness. This is especially true if the monitoring of the patient is remote, the motion is too small to be observed, or the doctor is watching the instrument or other parts of the patient, and not the sensor site. Processing pulse oximetry (i.e., PPG) signals may involve operations that reduce the amount of noise present in the signals or otherwise identify noise components in order to prevent them from affecting measurements of physiological parameters derived from the PPG signals. PPG signals may be taken herein to mean processed or filtered PPG signals.
It will be understood that the present disclosure is applicable to any suitable signals and that PPG signals are used merely for illustrative purposes. Those skilled in the art will recognize that the present disclosure has wide applicability to other signals including, but not limited to other biosignals (e.g., electrocardiogram, electroencephalogram, electrogastrogram, electromyogram, heart rate signals, pathological sounds, ultrasound, or any other suitable biosignal), dynamic signals, non-destructive testing signals, condition monitoring signals, fluid signals, geophysical signals, astronomical signals, electrical signals, financial signals including financial indices, sound and speech signals, chemical signals, meteorological signals including climate signals, and/or any other suitable signal, and/or any combination thereof.
In one embodiment, a PPG signal may be transformed using a continuous wavelet transform. Information derived from the transform of the PPG signal (i.e., in wavelet space) may be used to provide measurements of one or more physiological parameters.
The continuous wavelet transform of a signal x(t) in accordance with the present disclosure may be defined as
where ψ*(t) is the complex conjugate of the wavelet function ψ(t), a is the dilation parameter of the wavelet and b is the location parameter of the wavelet. The transform given by equation (9) may be used to construct a representation of a signal on a transform surface. The transform may be regarded as a time-scale representation. Wavelets are composed of a range of frequencies, one of which may be denoted as the characteristic frequency of the wavelet, where the characteristic frequency associated with the wavelet is inversely proportional to the scale a. One example of a characteristic frequency is the dominant frequency. Each scale of a particular wavelet may have a different characteristic frequency. The underlying mathematical detail required for the implementation within a time-scale can be found, for example, in Paul S. Addison, The Illustrated Wavelet Transform Handbook (Taylor & Francis Group 2002), which is hereby incorporated by reference herein in its entirety.
The continuous wavelet transform decomposes a signal using wavelets, which are generally highly localized in time. The continuous wavelet transform may provide a higher resolution relative to discrete transforms, thus providing the ability to garner more information from signals than typical frequency transforms such as Fourier transforms (or any other spectral techniques) or discrete wavelet transforms. Continuous wavelet transforms allow for the use of a range of wavelets with scales spanning the scales of interest of a signal such that small scale signal components correlate well with the smaller scale wavelets and thus manifest at high energies at smaller scales in the transform. Likewise, large scale signal components correlate well with the larger scale wavelets and thus manifest at high energies at larger scales in the transform. Thus, components at different scales may be separated and extracted in the wavelet transform domain. Moreover, the use of a continuous range of wavelets in scale and time position allows for a higher resolution transform than is possible relative to discrete techniques.
In addition, transforms and operations that convert a signal or any other type of data into a spectral (i.e., frequency) domain necessarily create a series of frequency transform values in a two-dimensional coordinate system where the two dimensions may be frequency and, for example, amplitude. For example, any type of Fourier transform would generate such a two-dimensional spectrum. In contrast, wavelet transforms, such as continuous wavelet transforms, are required to be defined in a three-dimensional coordinate system and generate a surface with dimensions of time, scale and, for example, amplitude. Hence, operations performed in a spectral domain cannot be performed in the wavelet domain; instead the wavelet surface must be transformed into a spectrum (i.e., by performing an inverse wavelet transform to convert the wavelet surface into the time domain and then performing a spectral transform from the time domain). Conversely, operations performed in the wavelet domain cannot be performed in the spectral domain; instead a spectrum must first be transformed into a wavelet surface (i.e., by performing an inverse spectral transform to convert the spectral domain into the time domain and then performing a wavelet transform from the time domain). Nor does a cross-section of the three-dimensional wavelet surface along, for example, a particular point in time equate to a frequency spectrum upon which spectral-based techniques may be used. At least because wavelet space includes a time dimension, spectral techniques and wavelet techniques are not interchangeable. It will be understood that converting a system that relies on spectral domain processing to one that relies on wavelet space processing would require significant and fundamental modifications to the system in order to accommodate the wavelet space processing (e.g., to derive a representative energy value for a signal or part of a signal requires integrating twice, across time and scale, in the wavelet domain while, conversely, one integration across frequency is required to derive a representative energy value from a spectral domain). As a further example, to reconstruct a temporal signal requires integrating twice, across time and scale, in the wavelet domain while, conversely, one integration across frequency is required to derive a temporal signal from a spectral domain. It is well known in the art that, in addition to or as an alternative to amplitude, parameters such as energy density, modulus, phase, among others may all be generated using such transforms and that these parameters have distinctly different contexts and meanings when defined in a two-dimensional frequency coordinate system rather than a three-dimensional wavelet coordinate system. For example, the phase of a Fourier system is calculated with respect to a single origin for all frequencies while the phase for a wavelet system is unfolded into two dimensions with respect to a wavelet's location (often in time) and scale.
The energy density function of the wavelet transform, the scalogram, is defined as
S(a,b)=|T(a,b)|2 (10)
where ‘∥’ is the modulus operator. The scalogram may be rescaled for useful purposes. One common rescaling is defined as
and is useful for defining ridges in wavelet space when, for example, the Morlet wavelet is used. Ridges are defined as the locus of points of local maxima in the plane. Any reasonable definition of a ridge may be employed in the method. Also included as a definition of a ridge herein are paths displaced from the locus of the local maxima. A ridge associated with only the locus of points of local maxima in the plane are labeled a “maxima ridge”.
For implementations requiring fast numerical computation, the wavelet transform may be expressed as an approximation using Fourier transforms. Pursuant to the convolution theorem, because the wavelet transform is the cross-correlation of the signal with the wavelet function, the wavelet transform may be approximated in terms of an inverse FFT of the product of the Fourier transform of the signal and the Fourier transform of the wavelet for each required a scale and then multiplying the result by √{square root over (a)}.
In the discussion of the technology which follows herein, the “scalogram” may be taken to include all suitable forms of rescaling including, but not limited to, the original unscaled wavelet representation, linear rescaling, any power of the modulus of the wavelet transform, or any other suitable rescaling. In addition, for purposes of clarity and conciseness, the term “scalogram” shall be taken to mean the wavelet transform, T(a,b) itself, or any part thereof. For example, the real part of the wavelet transform, the imaginary part of the wavelet transform, the phase of the wavelet transform, any other suitable part of the wavelet transform, or any combination thereof is intended to be conveyed by the term “scalogram”.
A scale, which may be interpreted as a representative temporal period, may be converted to a characteristic frequency of the wavelet function. The characteristic frequency associated with a wavelet of arbitrary a scale is given by
where fc, the characteristic frequency of the mother wavelet (i.e., at a=1), becomes a scaling constant and f is the representative or characteristic frequency for the wavelet at arbitrary scale a.
Any suitable wavelet function may be used in connection with the present disclosure. One of the most commonly used complex wavelets, the Morlet wavelet, is defined as:
ψ(t)=π−1/4(ei2πf
where f0 is the central frequency of the mother wavelet. The second term in the parenthesis is known as the correction term, as it corrects for the non-zero mean of the complex sinusoid within the Gaussian window. In practice, it becomes negligible for values of f0>>0 and can be ignored, in which case, the Morlet wavelet can be written in a simpler form as
This wavelet is a complex wave within a scaled Gaussian envelope. While both definitions of the Morlet wavelet are included herein, the function of equation (14) is not strictly a wavelet as it has a non-zero mean (i.e., the zero frequency term of its corresponding energy spectrum is non-zero). However, it will be recognized by those skilled in the art that equation (14) may be used in practice with f0>>0 with minimal error and is included (as well as other similar near wavelet functions) in the definition of a wavelet herein. A more detailed overview of the underlying wavelet theory, including the definition of a wavelet function, can be found in the general literature. Discussed herein is how wavelet transform features may be extracted from the wavelet decomposition of signals. For example, wavelet decomposition of PPG signals may be used to provide clinically useful information within a medical device.
Pertinent repeating features in a signal give rise to a time-scale band in wavelet space or a rescaled wavelet space. For example, the pulse component of a PPG signal produces a dominant band in wavelet space at or around the pulse frequency.
By mapping the time-scale coordinates of the pulse ridge onto the wavelet phase information gained through the wavelet transform, individual pulses may be captured. In this way, both times between individual pulses and the timing of components within each pulse may be monitored and used to detect heart beat anomalies, measure arterial system compliance, or perform any other suitable calculations or diagnostics. Alternative definitions of a ridge may be employed. Alternative relationships between the ridge and the pulse frequency of occurrence may be employed.
As discussed above, pertinent repeating features in the signal give rise to a time-scale band in wavelet space or a rescaled wavelet space. For a periodic signal, this band remains at a constant scale in the time-scale plane. For many real signals, especially biological signals, the band may be non-stationary; varying in scale, amplitude, or both over time.
In some instances, an inverse continuous wavelet transform may be desired, such as when modifications to a scalogram (or modifications to the coefficients of a transformed signal) have been made in order to, for example, remove artifacts. In one embodiment, there is an inverse continuous wavelet transform which allows the original signal to be recovered from its wavelet transform by integrating over all scales and locations, a and b:
which may also be written as:
where Cg is a scalar value known as the admissibility constant. It is wavelet type dependent and may be calculated from:
In this embodiment, signal 416 may be coupled to processor 412. Processor 412 may be any suitable software, firmware, and/or hardware, and/or combinations thereof for processing signal 416. For example, processor 412 may include one or more hardware processors (e.g., integrated circuits), one or more software modules, computer-readable media such as memory, firmware, or any combination thereof. Processor 412 may, for example, be a computer or may be one or more chips (i.e., integrated circuits). Processor 412 may perform the calculations associated with the continuous wavelet transforms of the present disclosure as well as the calculations associated with any suitable interrogations of the transforms. Processor 412 may perform any suitable signal processing of signal 416 to filter signal 416, such as any suitable band-pass filtering, adaptive filtering, closed-loop filtering, and/or any other suitable filtering, and/or any combination thereof.
Processor 412 may be coupled to one or more memory devices (not shown) or incorporate one or more memory devices such as any suitable volatile memory device (e.g., RAM, registers, etc.), non-volatile memory device (e.g., ROM, EPROM, magnetic storage device, optical storage device, flash memory, etc.), or both. The memory may be used by processor 412 to, for example, store data corresponding to a continuous wavelet transform of input signal 416, such as data representing a scalogram. In one embodiment, data representing a scalogram may be stored in RAM or memory internal to processor 412 as any suitable three-dimensional data structure such as a three-dimensional array that represents the scalogram as energy levels in a time-scale plane. Any other suitable data structure may be used to store data representing a scalogram.
Processor 412 may be coupled to output 414. Output 414 may be any suitable output device such as, for example, one or more medical devices (e.g., a medical monitor that displays various physiological parameters, a medical alarm, or any other suitable medical device that either displays physiological parameters or uses the output of processor 412 as an input), one or more display devices (e.g., monitor, PDA, mobile phone, any other suitable display device, or any combination thereof), one or more audio devices, one or more memory devices (e.g., hard disk drive, flash memory, RAM, optical disk, any other suitable memory device, or any combination thereof), one or more printing devices, any other suitable output device, or any combination thereof.
It will be understood that system 400 may be incorporated into system 10 (
PPG signal 505 may exhibit an oscillatory behavior versus time, and may include several undulations of varying signal amplitude level and frequency. The size, shape, and frequency of the undulations of PPG signal 505 may be indicative of an underlying parameter or phenomenon that is to be detected or estimated. For example, PPG signal 505 may reflect the breaths or breathing cycle of a patient, such as patient 40 (
It may be advantageous to select the consistent parts of PPG signal 505 prior to determining (e.g., detecting or estimating) an underlying parameter, such as the respiration rate of a patient, from PPG signal 505. The consistent parts of PPG signal 505 may be used to accurately determine the underlying parameter, at least because the consistent parts of PPG signal 505 may include relative low noise and or be time-invariant with respect to the value of the underlying parameter. Further, the consistent parts of PPG signal 505 may exhibit statistical regularity, and/or may other features that match closely or identically the features used to derive signal processing algorithms, including parameter detection and estimation algorithms. Therefore, such signal processing algorithms may exhibit relatively strong performance, e.g., detection or estimation performance, when applied to the consistent parts of PPG signal 505. To select consistent parts of PPG signal 505, several features of the signal may be used. For example, signal peaks 510, 512, 514, 516, and 518 may be identified and used to determine consistency. Alternatively or additionally, signal troughs 520, 522, 524, 526, and/or 528 may be used. In an embodiment, the interpeak distances 530, 532, 534, and 536 may be used. In an embodiment, the peaks of the first, second, or any other suitable derivative of PPG signal 505 may be used to determine consistency. These and other features and characteristic points of PPG signal 505 may be used separately or in combination to select a consistent part (or parts) of PPG signal 505. For example, process 600 (depicted in
Although the techniques disclosed herein are described in terms of PPG signal 505, the disclosed techniques may be applied to any other suitable signal. For example, the disclosed techniques may be applied to other biological signals (i.e., biosignals) including transthoracic impedence signals, and/or capnograph signals. Further, PPG signal 505 or any other related signal may be obtained from a source other than pulse oximeter system 10 (
Process 600 may start at step 610. At step 620, process 600 may obtain a signal. The obtained signal may be a PPG signal such as PPG signal 505 (
The signal obtained at step 620 may be obtained by first obtaining a preliminary PPG signal and processing the preliminary PPG signal. The preliminary PPG signals may be obtained using, e.g., sensor 12 (
At step 630, a portion of the signal obtained in step 620 may be selected for analysis. For example, a time-window may be applied to the signal obtained in step 620 by a processor such as processor 412 (
At step 650, peaks identified in current and past iterations of step 640 of process 600 may be processed according to a consistency metric. For example, the consistency metric may specify a target number of suitable signal amplitude peaks (e.g., three peaks). In this case, signal peak values may be processed until three consecutive signal peaks have been identified, as further described according to particular embodiments by process 700 (
At step 660, the processed peak data obtained at step 640 may be compared to the consistency metric to determine if signal obtained at step 620 is consistent. For example, if the consistency metric specifies three signal peaks having amplitude levels within a certain range, then the processed peak data determined at step 650 may be compared to this condition (i.e., consistency metric) at step 660. At step 670, the selected portion of the signal determined in step 630, or a processed version, may be used for further analysis. For example, the signal may be used to determine a rate of occurrence of certain features, such as a respiration rate of a patient (e.g., patient 40 (
Process 700 may start at step 702. At step 702, the amplitude of a first signal peak may be identified. For example, at step 702, process 700 may search a signal obtained by process 600 (
At step 704, upper and lower thresholds may be set relative to the amplitude of the signal peak identified in step 702. In an embodiment, an upper threshold may be set at an amplitude value larger than the amplitude of the first signal peak, and a lower threshold may be set at an amplitude value lower than the amplitude of the first signal peak. For example, for PPG signal 505 (
At step 708, process 700 may determine if the amplitude of the signal peak identified in step 706 lies within a threshold region. For example, signal peak 512 (
At step 712, process 700 may determine if a target number (or predetermined number) of consecutive signal peaks have been found through consecutive iterations of process 700, for which the amplitudes of the consecutive signal peaks all lie within the threshold region. For example, process 700 may operate on PPG signal 505 (
If, at step 708, the amplitude of signal peak is determined not to lie within the threshold region (for example, in
Process 700 may be used to identify the most signal peaks using the lowest threshold values and/or the smallest threshold region. Consecutive iterations of process 700 may fail to produce the target number of desired signal peaks, or it may produce signal peaks infrequently. Process 700 may increase the number and/or frequency of identified signal peaks by, for example, increasing the breadth of the threshold region by raising the upper threshold amplitude value and lowering the lower threshold amplitude value simultaneously. This may increase the number of signal peaks counted in the threshold region (e.g., the threshold region defined by amplitude values 550 and 560 in
In an alternative embodiment, process 700 may, as a first step, identify all of the signal peaks within a given threshold region. For example, process 700 may be used to analyze PPG signal 505 (
Process 725 may begin at step 727, where the amplitude of a first signal peak (of an obtained signal) may be identified. For example, the amplitude of a first signal peak may be determined similarly or identically to that of step 702 (
At step 735, process 725 may force the signal peak identified in step 731 to lie within the threshold band. For example, process 735 may uniformly scale the signal peak (and related adjacent signal components) so that the resultant portion of the signal including the modified signal peak lies within the threshold band. Alternatively, process 735 may use quantization, rounding, or any suitable template-matching technique so that the resulting portion of the signal including the signal peak lies within the threshold band. Further, process 725 may, at step 735, remove, splice, transform, or otherwise modify the portion of the signal that lies outside the threshold region, and/or may concatenate the remaining portion of the signal so that the resultant signal is continuous in time.
At step 737, process 725 may determine if a target number (or predetermined number) of consecutive signal peaks have been found. For example, process 725 may operate on PPG signal 510 (
If, at step 737, the target number of signal peaks has not been found, process 725 may continue to selected another signal peak by returning to step 729. At step 729, process 725 may reset the upper and lower threshold values. Therefore, upper and lower threshold values may vary over time, e.g., to account for drift in the feature amplitude, period, or general morphology of the obtained signal. Process 725 may then return to step 731, where the amplitude of a next signal peak is identified.
Processes 700 (
Process 750 may start at step 752. At step 752, the amplitude values of all the signal peaks of the obtained signal may be identified. For example, at step 752, process 750 may search the signal obtained by process 600 (
At step 754, process 750 may set threshold regions for each signal peak identified at step 752 (i.e., process 750 may set threshold regions on a peak-by-peak basis). For example, process 750 may obtain PPG signal 780 (
Process 750 may then identify the number of consecutive signal peaks for which each signal peak amplitude value is within the threshold region of the previous signal peak. In an embodiment, process 750 may implement this peak-counting technique as follows. At step 756, process 750 may set a counter peak_count equal to the value one, where peak_count represents the number of consecutively identified valid signal peak amplitude values. At step 758, process 750 may determine if a current signal peak lies within the threshold range corresponding to a previous signal peak. For example, if the current signal peak is signal peak 788 (
If the current signal peak is determined to lie within the previous threshold range at step 758, process 750 may continue to step 762, where the value of peak_count may be incremented (i.e., signifying that the current peak has been identified to be a valid signal peak). Process 750 may then continue to step 764, where process 750 may determine if a target number of consecutive signal peaks have been identified or found (e.g., by comparing the value of peak_count to a specified threshold). If the target number of signal peaks have been found, process 750 may continue to step 766, where process 750 may process the signal by, e.g., normalizing the portion of the signal corresponding to the signal peaks (i.e., the consistent part of the signal). For example, process 750 may filter the signal corresponding to the signal peaks to normalize signal peak values, remove noise-artifacts, and/or perform curve smoothing and interpolation operations. In alternative embodiment of process 750, if the target number of signal peaks are not found at step 764, process 750 may instead return to step 758 and continue to identify value signal peaks (rather than continue to step 766). If at step 764, it is determined that the target number of consecutive signal peaks have not been identified, process 750 may return to step 758, and continue to test signal peaks.
If, at step 758, the current signal peak is determined not to fall within the threshold region of the previous signal peak, then process 750 may continue to step 760. At step 760, process 750 may test the signal obtained, e.g., at step 620 of process 600 (both of
Process 800 may start at step 810, where a first interpeak distance of a signal is calculated. For example, step 810 may determine interpeak distances of a signal obtained by process 600 (
Process 800 may continue at step 820, where the determined interpeak distance is compared to a criterion, e.g., a length-threshold, a variance metric, and/or an average signal power metric. Additionally, the criterion may depend on previous and/or future values of the interpeak distances determined, e.g., at step 810 during previous iterations of process 800. Thresholds and other parameters used to calculate the criterion at step 820 may be based on analytic results, on experimental data, and/or may be determined heuristically. For example, these thresholds and parameters may be set by, e.g., using user inputs 56 (
At step 830, a decision may be made regarding the suitability of the interpeak distance determined at step 810. The decision may be made by comparing the interpeak distance determined at step 810 to a threshold determined at step 820. Further, an interpeak distance (e.g., interpeak distance 534 of
If, at step 830, the interpeak distance is determined to be suitable, process 800 may continue to step 840. At step 840, process 800 may determine if a target or predetermined number of interpeak periods have been found through consecutive iterations of process 800. For example, process 800 may operate on PPG signal 505 (
At step 870, process 800 may continue to determine and analyze interpeak periods by identifying a next interpeak period. For example, if the last identified interpeak period (identified either at step 810 or at a previous iteration of step 870) was, e.g., interpeak period 532 (
The criteria and metrics described, e.g., at step 650 (
Consistency in amplitude techniques (described for example, in
The techniques described above (e.g., in
At step 910, the wavelet transform of a signal may be obtained. Such a wavelet transform may be obtained, for example, by system 10 (
At step 930, the respiration band of a scalogram may be identified based on one or more characteristics of the scalogram obtained in step 920. The respiration band of the scalogram may generally reflect the breathing pattern of a patient, e.g., patient 40 (
At step 940, the scalogram characteristics determined in step 930 corresponding to the respiration band may be analyzed. Analyzing the characteristics may generally involve parsing, combining, and/or weighing results obtained in previous steps of process 900 to obtain a single, overall estimate of the respiration rate. Step 940 may incorporate the use of past scalogram data that has been obtained in previous iterations of process 900 to determine a respiration rate. The respiration rate may be represented by a number from 1 to 100, where a larger number indicates a larger respiration rate (any other suitable number range could be used instead). Step 940 may also involve the parameterization and/or curve fitting of data obtained in steps 920 and 930 using, for example, linear least-squares fitting of data or any other suitable interpolation technique. Such parameterization and/or curve fitting may be performed, for example, by processor 412 (
At step 950, the respiration rate determined or estimated at step 940 may be reported. For example, the respiration rate may be reported by generating an audible alert or, for example, using speaker 22 (
It will also be understood that the above method may be implemented using any human-readable or machine-readable instructions on any suitable system or apparatus, such as those described herein.
The foregoing is merely illustrative of the principles of this disclosure and various modifications may be made by those skilled in the art without departing from the scope and spirit of the disclosure. The following claims may also describe various aspects of this disclosure.
This application is a continuation of U.S. patent application Ser. No. 12/437,326, filed on May 7, 2009, which claims priority to U.S. Provisional Application No. 61/077,062, filed Jun. 30, 2008, and U.S. Provisional Application No. 61/077,130, filed Jun. 30, 2008, all of which are incorporated herein by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
4800495 | Smith | Jan 1989 | A |
5218962 | Mannheimer et al. | Jun 1993 | A |
5381803 | Herleikson et al. | Jan 1995 | A |
5482036 | Diab et al. | Jan 1996 | A |
5490505 | Diab et al. | Feb 1996 | A |
5517988 | Gerhard | May 1996 | A |
5558096 | Palatnik | Sep 1996 | A |
5595176 | Yamaura | Jan 1997 | A |
5632272 | Diab et al. | May 1997 | A |
5685299 | Diab et al. | Nov 1997 | A |
5713355 | Richardson et al. | Feb 1998 | A |
5769785 | Diab et al. | Jun 1998 | A |
6002952 | Diab et al. | Dec 1999 | A |
6036642 | Diab et al. | Mar 2000 | A |
6067462 | Diab et al. | May 2000 | A |
6081735 | Diab et al. | Jun 2000 | A |
6206830 | Diab et al. | Mar 2001 | B1 |
6263222 | Diab et al. | Jul 2001 | B1 |
6501975 | Diab et al. | Dec 2002 | B2 |
6519486 | Edgar, Jr. et al. | Feb 2003 | B1 |
6631281 | Kastle | Oct 2003 | B1 |
6654623 | Kastle | Nov 2003 | B1 |
6654624 | Diab et al. | Nov 2003 | B2 |
6684090 | Ali et al. | Jan 2004 | B2 |
RE38476 | Diab et al. | Mar 2004 | E |
6699194 | Diab et al. | Mar 2004 | B1 |
RE38492 | Diab et al. | Apr 2004 | E |
6805673 | Dekker | Oct 2004 | B2 |
6810277 | Edgar, Jr. et al. | Oct 2004 | B2 |
6811538 | Westbrook et al. | Nov 2004 | B2 |
6816741 | Diab | Nov 2004 | B2 |
6822564 | Al-Ali | Nov 2004 | B2 |
6826419 | Diab et al. | Nov 2004 | B2 |
6839659 | Tarassenko et al. | Jan 2005 | B2 |
6852083 | Caro et al. | Feb 2005 | B2 |
6996427 | Ali et al. | Feb 2006 | B2 |
7006856 | Baker, Jr. et al. | Feb 2006 | B2 |
7020507 | Scharf et al. | Mar 2006 | B2 |
7072702 | Edgar, Jr. et al. | Jul 2006 | B2 |
7139599 | Terry | Nov 2006 | B2 |
7162288 | Nordstrom et al. | Jan 2007 | B2 |
7248910 | Li et al. | Jul 2007 | B2 |
7355512 | Al-Ali | Apr 2008 | B1 |
7367339 | Hickle | May 2008 | B2 |
7381188 | Farazi | Jun 2008 | B1 |
7407485 | Huiku | Aug 2008 | B2 |
7460899 | Almen | Dec 2008 | B2 |
7499740 | Nordstrom et al. | Mar 2009 | B2 |
7582061 | Li et al. | Sep 2009 | B2 |
8478538 | McGonigle et al. | Jul 2013 | B2 |
8532932 | McGonigle et al. | Sep 2013 | B2 |
20030036685 | Goodman | Feb 2003 | A1 |
20050004479 | Townsend et al. | Jan 2005 | A1 |
20050197579 | Baker, Jr. | Sep 2005 | A1 |
20060135860 | Baker, Jr. et al. | Jun 2006 | A1 |
20060137577 | Chang et al. | Jun 2006 | A1 |
20060195025 | Ali et al. | Aug 2006 | A1 |
20060241708 | Boute | Oct 2006 | A1 |
20060258921 | Addison et al. | Nov 2006 | A1 |
20060258927 | Edgar, Jr. et al. | Nov 2006 | A1 |
20070238937 | Chang et al. | Oct 2007 | A1 |
20080262326 | Hete et al. | Oct 2008 | A1 |
20090326351 | Addison et al. | Dec 2009 | A1 |
20090326395 | Watson | Dec 2009 | A1 |
20090326831 | McGonigle et al. | Dec 2009 | A1 |
Number | Date | Country |
---|---|---|
0429025 | May 1991 | EP |
0801960 | Oct 1997 | EP |
WO 0021438 | Apr 2000 | WO |
Entry |
---|
Dyck, W. and Collette, M.: “A microcontroller-based device for monitoring blood pressure in the field”, Defence Research Establishment Ottawa, Technical Note, vol. 93, No. 29, Jun. 1994, XP002609850, *abstract: figures 4,5, p. 16, line 19—p. 17, line 4. |
PCT International Search Report, International Application No. PCT/IB2009/006182, Applicant: Nellcor Puritan Bennett Ireland, Date of Mailing: Dec. 21, 2010, International Filing Date: Jun. 29, 2009. |
Addison, Paul S., The Illustrated Wavelet Transform Handbook, Taylor & Francis Group, 2002. |
Number | Date | Country | |
---|---|---|---|
20140012109 A1 | Jan 2014 | US |
Number | Date | Country | |
---|---|---|---|
61077062 | Jun 2008 | US | |
61077130 | Jun 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12437326 | May 2009 | US |
Child | 14020547 | US |